PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Elekta Limited

USPTO PatentsView assignee record - 190 granted patents across 36 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

Explore the portfolio See the ranking
190
Total patents granted
36
CPC technology areas
20.8
Avg claims per patent
+232%
5-year filing velocity

The verdict

Elekta holds 190 US patents across 36 technology areas, rank #2,079 of 50,000 tracked assignees.

#2,079
of 50,000 US assignees by volume
Top 6%
by Innovation Score (57.0/100)
20.8
avg claims per patent
+232%
filing velocity, last 5 yrs

Portfolio overview

Elekta Limited has been granted 190 US utility patents between 2015 and 2025, placing Elekta Limited at rank #2,079 across all assignees tracked by PlainPatent. This portfolio spans 36 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.8 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Elekta Limited is one of the more focused assignees in the PatentsView dataset. By volume, Elekta sits between Stolle Machinery Company, Llc (191 patents, rank #2,075) and Rigel Pharmaceuticals, Inc. (190 patents, rank #2,083) - the closest US assignees by grant volume. The composite Innovation Score of 57.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 146 grants, compared with 44 in the 2015–2019 window, a +232% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Elekta Limited's 20.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 36 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Elekta Limited against peers pursuing similar technology classes.

Who files at Elekta's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Elekta holds 190 patents at rank #2,079, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Elekta

By rank, the assignees closest to #2,079 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Elekta's primary technology class.

Elekta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20152016201720182019202020212022202320242025 34
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Elekta Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 1.1%
2016 2 1.1%
2017 3 1.6%
2018 11 5.8%
2019 26 13.7%
2020 32 16.8%
2021 20 10.5%
2022 19 10.0%
2023 17 8.9%
2024 24 12.6%
2025 34 17.9%

Which technologies does Elekta Limited patent most?

Top 15 of 36 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#2,079

Across all tracked assignees

Innovation Score

57.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Elekta Limited hold?
Elekta Limited holds 190 US granted patents filed between 2015 and 2025, spanning 36 technology areas.
What is Elekta Limited's Innovation Score?
Elekta Limited has an Innovation Score of 57.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Elekta Limited focus on?
Elekta Limited's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 156 patents. The company has filed patents in 36 CPC subclasses total.
Is Elekta Limited's patent filing rate increasing or decreasing?
Elekta Limited's recent filing velocity is +232% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Elekta Limited's patents?
Elekta Limited's patents average 20.8 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Elekta Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Elekta's 190 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Elekta ranks #2,079 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.